CR10057A - Compuesto heterocíclico fusionado - Google Patents

Compuesto heterocíclico fusionado

Info

Publication number
CR10057A
CR10057A CR10057A CR10057A CR10057A CR 10057 A CR10057 A CR 10057A CR 10057 A CR10057 A CR 10057A CR 10057 A CR10057 A CR 10057A CR 10057 A CR10057 A CR 10057A
Authority
CR
Costa Rica
Prior art keywords
heterocyclic compound
fused heterocyclic
alkyl group
hydrogen atom
alkyl
Prior art date
Application number
CR10057A
Other languages
English (en)
Inventor
Ishikawa Tomoyasu
Miwa Kazuhiro
Seto Masaki
Banno Hiroshi
Kawakita Youichi
Original Assignee
Incyte Corp
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Takeda Pharmaceutical filed Critical Incyte Corp
Publication of CR10057A publication Critical patent/CR10057A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención provee un compuesto representado por la fórmula en donde R 1a es un átomo de hidrógeno, R 2a es un grupo alquilo de C1-6 sustituido como un grupo representado por alquilo de C1-4 opcionalmente halogenado con -NR 6a-CO-(CH2)n-SO2- en donde n es un número entero de 1 a 4, R 6a es un átomo de hidrógeno o un grupo alquilo de C1-4, y -(CH2)n- esta opcionalmente sustituido con alquilo de C1-4, R 3a es un átomo de hidrógeno o un grupo alquilo de C 1-6, R 4a es un átomo de halógeno o un grupo alquilo de C1-6.
CR10057A 2005-12-02 2008-06-09 Compuesto heterocíclico fusionado CR10057A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005349858 2005-12-02
JP2006060648 2006-03-07

Publications (1)

Publication Number Publication Date
CR10057A true CR10057A (es) 2008-07-29

Family

ID=37897379

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10057A CR10057A (es) 2005-12-02 2008-06-09 Compuesto heterocíclico fusionado

Country Status (15)

Country Link
US (1) US20100216788A1 (es)
EP (1) EP1957495A1 (es)
JP (1) JP2009517333A (es)
KR (1) KR20080084823A (es)
AR (1) AR057961A1 (es)
AU (1) AU2006319787A1 (es)
BR (1) BRPI0619911A2 (es)
CA (1) CA2631066A1 (es)
CR (1) CR10057A (es)
MA (1) MA30046B1 (es)
NO (1) NO20082870L (es)
PE (1) PE20071089A1 (es)
RU (1) RU2008126949A (es)
TW (1) TW200730527A (es)
WO (1) WO2007064045A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MEP8409A (en) * 2004-06-02 2011-12-20 Fused heterocyclic compound
RU2009126576A (ru) * 2006-12-12 2011-01-20 Такеда Фармасьютикал Компани Лимитед (Jp) Конденсированное гетероциклическое соединение
US7825127B2 (en) 2006-12-28 2010-11-02 Takeda Pharmaceutical Company, Limited Method for treating cancer
RU2010101416A (ru) 2007-06-19 2011-07-27 Такеда Фармасьютикал Компани Лимитед (Jp) Профилактическое/лекарственное средство от рака
TW200940546A (en) * 2008-03-03 2009-10-01 Takeda Pharmaceutical Combination drug
TW200944528A (en) * 2008-03-12 2009-11-01 Takeda Pharmaceutical Fused heterocyclic compound
AU2012273133A1 (en) 2011-06-20 2013-11-07 E. I. Du Pont De Nemours And Company Heterocyclic compounds for treating helminth infections
WO2013159095A1 (en) 2012-04-20 2013-10-24 Anderson Gaweco Ror modulators and their uses
PT3049417T (pt) * 2013-07-31 2019-01-24 Merck Patent Gmbh Piridinas, pirimidinas e pirazinas, como inibidores de btk e utilizações das mesmas
GB201520499D0 (en) * 2015-11-20 2016-01-06 Medical Res Council Technology Compounds
AR119494A1 (es) * 2019-07-29 2021-12-22 Servier Lab DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS
US12037346B2 (en) 2021-04-13 2024-07-16 Nuvalent, Inc. Amino-substituted heteroaryls for treating cancers with EGFR mutations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
MEP8409A (en) * 2004-06-02 2011-12-20 Fused heterocyclic compound
ES2438017T3 (es) * 2004-07-30 2014-01-15 Methylgene Inc. Inhibidores de la señalización del receptor del VEGF y del receptor del HGF
TW200740820A (en) * 2005-07-05 2007-11-01 Takeda Pharmaceuticals Co Fused heterocyclic derivatives and use thereof

Also Published As

Publication number Publication date
TW200730527A (en) 2007-08-16
WO2007064045A1 (en) 2007-06-07
RU2008126949A (ru) 2010-01-10
AU2006319787A1 (en) 2007-06-07
PE20071089A1 (es) 2007-11-19
AR057961A1 (es) 2007-12-26
MA30046B1 (fr) 2008-12-01
US20100216788A1 (en) 2010-08-26
EP1957495A1 (en) 2008-08-20
JP2009517333A (ja) 2009-04-30
CA2631066A1 (en) 2007-06-07
KR20080084823A (ko) 2008-09-19
NO20082870L (no) 2008-09-01
BRPI0619911A2 (pt) 2016-08-30

Similar Documents

Publication Publication Date Title
CR10057A (es) Compuesto heterocíclico fusionado
CR9048A (es) Analogos de anilino-pirimidina
PE20120010A1 (es) Cefalosporinas que tienen un grupo catecol
CY1112914T1 (el) Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης
TN2011000286A1 (en) Spiroheterocyclic n-oxypiperidines as pesticides
CR8827A (es) Compuesto heterociclico fusionado
CY1112705T1 (el) Συντηγμενες κυκλικες ενωσεις
JO2853B1 (en) Sulfonamides as TRPM8 organizations
BR112015032689A2 (pt) composto heterocíclico fundido e uso em controle de pragas do mesmo
PH12014502211A1 (en) Alkyl phenyl sulfide derivative and pest control agent
BR112018006292A2 (pt) ?composição fungicida para uso agrícola e hortícola?
CR9369A (es) Compuestos de peridil acido acetico
CO6321166A2 (es) Compuestos de pirrol
EA201591497A1 (ru) Новые производные октагидропирроло[3,4-c]пиррола и их аналоги в качестве ингибиторов аутотаксина
CO6220910A2 (es) Proceso para la producir compuestos pesticidas de benzamidas
CY1119220T1 (el) Μονοκυκλικο παραγωγο πυριδινης
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
BR112017006428A2 (pt) composto piridazina
BRPI0411268C8 (pt) Processo para a preparação de compostos 3-aril butil-amina substituído
CY1117157T1 (el) Υποκατεστημενο παραγωγο ισοκινολινης
EA201070246A1 (ru) Циклические аминные соединения
BR112016001979A2 (pt) composto de tetrazolinona e uso do mesmo
BR112013018732A2 (pt) novos derivados de amida de aril-benzocicloalquila
PE20170439A1 (es) Derivados de bis(aril)catecol como herbicidas
CY1121626T1 (el) Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)